VivoSim Labs, INC. financial data

Symbol
VIVS on Nasdaq
Location
San Diego, CA
Fiscal year end
31 March
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 280% % 0.66%
Quick Ratio 9% %
Debt-to-equity 46% % -17.9%
Return On Equity -29% % 88.4%
Return On Assets -20% % 87.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2,607,962 shares -83%
Common Stock, Shares, Outstanding 2,607,962 shares -83%
Entity Public Float $7,720,472 USD 972%
Common Stock, Value, Issued $3,000 USD -80%
Weighted Average Number of Shares Outstanding, Basic 2,604,950 shares 73.7%
Weighted Average Number of Shares Outstanding, Diluted 2,604,950 shares 73.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $140,000 USD 35.9%
Research and Development Expense $4,563,000 USD -6.55%
Costs and Expenses $12,312,000 USD -4.36%
Operating Income (Loss) $-12,172,000 USD 4.68%
Nonoperating Income (Expense) $10,191,000 USD 4331%
Income Tax Expense (Benefit) $2,000 USD 0%
Net Income (Loss) Attributable to Parent $-1,983,000 USD 84.2%
Earnings Per Share, Basic 0 USD/shares 41.7%
Earnings Per Share, Diluted 0 USD/shares 41.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $6,677,000 USD 110%
Accounts Receivable, after Allowance for Credit Loss, Current $32,000 USD 10.3%
Inventory, Net $0 USD -100%
Other Assets, Current $12,000 USD 200%
Assets, Current $7,591,000 USD 58.7%
Property, Plant and Equipment, Net $300,000 USD -45%
Operating Lease, Right-of-Use Asset $641,000 USD -41%
Assets $9,686,000 USD 43.4%
Accounts Payable, Current $580,000 USD 38.4%
Employee-related Liabilities, Current $229,000 USD -35.7%
Accrued Liabilities, Current $771,000 USD -12.3%
Liabilities, Current $2,449,000 USD 1.45%
Operating Lease, Liability, Noncurrent $172,000 USD -73.9%
Liabilities $2,621,000 USD -14.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $1,000 USD 0%
Retained Earnings (Accumulated Deficit) $-347,545,000 USD -0.57%
Stockholders' Equity Attributable to Parent $7,065,000 USD 92%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $7,065,000 USD 92%
Liabilities and Equity $9,686,000 USD 43.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $-3,940,000 USD -32.1%
Net Cash Provided by (Used in) Financing Activities $1,683,000 USD -73.1%
Net Cash Provided by (Used in) Investing Activities $0 USD -100%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 2,607,962 shares -83%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $-2,257,000 USD -169%
Interest Paid, Excluding Capitalized Interest, Operating Activities $4,000 USD
Deferred Tax Assets, Valuation Allowance $2,807,000 USD -5.9%
Deferred Tax Assets, Gross $3,061,000 USD -9.33%
Operating Lease, Liability $700,000 USD -40.3%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $-2,545,000 USD 0.12%
Lessee, Operating Lease, Liability, to be Paid $730,000 USD -42.1%
Property, Plant and Equipment, Gross $1,940,000 USD 0.68%
Operating Lease, Liability, Current $528,000 USD 2.92%
Lessee, Operating Lease, Liability, to be Paid, Year Two $459,000 USD -0.22%
Lessee, Operating Lease, Liability, to be Paid, Year One $271,000 USD -49.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $30,000 USD -65.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three $538,000 USD 0%
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $460,000 USD 0%
Operating Lease, Payments $532,000 USD 2.9%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $61,000 USD -12.9%
Deferred Tax Assets, Net of Valuation Allowance $254,000 USD -35.4%
Share-based Payment Arrangement, Expense $371,000 USD -44.5%